Company insight
Four of the industry’s most pressing challenges
From geopolitical upheaval to the climate crisis, companies in all industries are facing unprecedented challenges. Pharmaceutical and medical device manufacturers are seeking to bring new products to market in a disrupted and ever-changing environment. Companies must have strategies in place to keep their assembly systems running as well as optimise new product development. We examine the key hurdles affecting the industry and how Mikron Automation is facing them down.
T
he Covid-19 pandemic and war in Europe have significantly disrupted global supply chains, creating a major challenge for the medical devices industry. When it comes to building the assembly systems for medical devices, a widespread shortage in electronic components has threatened productivity.
Leading assembly solution provider, Mikron Automation, has developed strategies to ensure they can source required parts, explains Mikron COO Rolf Rihs: “We have to plan and forecast our material purchases from the market,” he says. “Previously, we planned maybe half a year ahead, but we have now extended that substantially. Early anticipation has helped us to avoid major difficulties.”
One of the knock-on effects of disrupted supply chains has been price hikes, with some components costing up to ten times more than before. For Mikron, it has taken great efforts and flexibility from across the workforce to secure the right suppliers. “We also have a sizeable in-house manufacturing capacity for metal parts, and that has helped us very much,” Rihs adds.
The good news is that global electronic chip production is beginning to recover, and shipping capacity is returning to normal. “I am an optimist,” says Rihs. “I believe that by mid-next year, the situation will not be perfect, but it will be better.”
Talent shortages
According to ManpowerGroup, 75% of global companies have recorded a talent shortage this year, and this problem continues to grow. For pharmaceutical and medical device assembly lines, more engineers and technicians are required than the market can provide. Companies can make use of education to develop their own pipelines for
talent. “We are running a large apprenticeship programme in Switzerland and at our site in the US,” Rihs explains. “At our headquarters, we have 46 apprentices learning to be polymechanics. They will learn all the necessary skills a technician will need later.” Thanks to the dual education system in Switzerland, a good part of the polymechanics will continue their education with an engineering degree. And with employees demanding more comfort and flexibility from their workspaces, Mikron has invested more than 20 million Swiss francs into a new modern office setup to make its work environment more attractive.
The race to market Time to market is crucial in gaining a competitive advantage. In order to keep up, manufacturers need new ways to make time savings. “In the past, they developed a device, tested it, then sourced an assembly system,” says Rihs. “To cut the time to market, we can parallelise the final development of the product and the building of the assembly system, and help our customers gain speed.” At the same time, growing demand for more complex products means that manufacturers require larger assembly programmes than ever, often with two or more in parallel. Mikron Automation meets the needs of the largest programmes in the shortest time frame by leveraging the capacity of the entire company. Another way to save time downstream is to avoid mistakes and optimise designs from their conception. Mikron brings to the table 50 years of assembly experience to advise its customers on how to best design their products for manufacturing.
“The assembly system is a vital piece of the product launch,” says Rihs. “Mikron has
Medical Device Developments /
www.nsmedicaldevices.com
done a very good job over the years and proven to our customers that we are here for them when they need us.”
ESG standards
Environmental, social and governance (ESG) investment has been accelerating since 2014, according to Forbes. Stakeholders are demanding accountability from businesses, and pharmaceutical companies must be able to prove their commitment. “It’s high on our management agenda,” says Rihs. Mikron is leading by example, taking steps to define and work towards 2025 and 2030 targets in areas including sustainability and diversity. For example, the new Switzerland factory includes solar panels which generate about 25% of the building’s electrical consumption, and gas heating has been replaced by a CO2
-neutral heat pump system.
For manufacturers, a well-designed, high- precision assembly system enables energy- efficient product assembly which is planned with the highest standards in mind.
Meeting the challenges
Innovation is fundamental to meeting new challenges, and as the world changes around us, advanced technologies are unlocking new possibilities for manufacturers in all industries. Digitisation, for example, is creating efficiencies for Mikron customers. An assembly system generates millions of data points per hour, and Mikron is helping manufacturers to access and analyse that data to optimise their operations. “We want to continue our journey of investing in innovation and making sure that we are using the best available technologies in our assembly systems,” says Rihs. “This is a key part of our past and future success.” ●
www.mikron.com/automation 47
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140
